Poewe W H
Department of Neurology, Universitätsklinikum Rudolf Virchow, Freie Universität Berlin, Germany.
Neurology. 1994 Jul;44(7 Suppl 6):S6-9.
Fluctuations in motor response eventually affect most patients with Parkinson's disease who have been exposed to chronic, intermittent levodopa administration for longer than 5 years. Response oscillations are often related to the timing of levodopa doses (predictable "wearing-off"), but random "on-off" effects also occur in one subgroup of patients. The underlying pathophysiology of each type of effect may be different. Treatment also differs: Patients with complex refractory oscillations may benefit from continuous dopaminergic stimulation with enteral infusions of levodopa or subcutaneous infusions of apomorphine. Three major types of abnormal drug-induced involuntary movements (interdose and biphasic dyskinesias and "off-period" dystonia) accompany these response oscillations in most patients, making fluctuating Parkinson's disease symptoms the most challenging problem in antiparkinsonian therapy. The underlying mechanisms for motor fluctuations have only been partially explained, and preventive treatment strategies have yet to be defined in properly designed prospective long-term studies.
运动反应波动最终会影响大多数帕金森病患者,这些患者长期(超过5年)接受间歇性左旋多巴治疗。反应波动通常与左旋多巴剂量的时间安排有关(可预测的“剂末现象”),但在一部分患者中也会出现随机的“开-关”效应。每种效应的潜在病理生理学可能不同。治疗方法也有所不同:复杂难治性波动的患者可能从左旋多巴肠内输注或阿扑吗啡皮下输注的持续多巴胺能刺激中获益。在大多数患者中,三种主要类型的药物诱发异常不自主运动(剂间和双相异动症以及“关期”肌张力障碍)伴随着这些反应波动,这使得帕金森病症状波动成为抗帕金森病治疗中最具挑战性的问题。运动波动的潜在机制仅得到部分解释,在设计合理的前瞻性长期研究中尚未确定预防性治疗策略。